Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

36 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-06

Study Completion Date

2019-04-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Burn injury leads to hypovolemic then distributive shock. Fluid resuscitation remains the cornerstone of initial treatment of burn shock. However, fluid rescucitation can lead to fluid overload, which manifests most notably as lung edema.

The peptide NT-pro-BNP, a biomarker of cardiac congestion secreted by the myocardium, as well as plasma CD146, an endothelial factor involved in angiogenesis and a marker of vascular congestion, may help identifying patients with risk of pulmonary edema and hypoxia .

Our hypothesis is that these biomarkers may predict the occurence of pulmonary edema in severe burns patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

BIOmarkers of Dyspnea IN Emergency Room

NCT01227317

Severe Dyspnea CAPD AE COPD +2 more

COMPLETED

Exploring the Relationship Among BNP, Fluid Status and Acute Kidney Injury in Critically Ill Patients

NCT02095275

Acute Kidney Injury (Nontraumatic)

UNKNOWN

BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED

NCT00587938

Congestive Heart Failure

COMPLETED

Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema

NCT07338227

Clara Cell Protein Diagnostic Biomarker Differentiation +2 more

COMPLETED

Prehospital Triage of Patients With Severe Shortness of Breath Using Biomarkers

NCT02050282

Dyspnea

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burns

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intubated mechanically-ventilated patients within the first 24 hours of admission
* And/or patients with total body surface area (TBSA) burn-injured \>20 %
* And/or patients with at least 10% full-thickness burns
* And/or receiving vasopressors within the first 24 hours of admission
* And monitored by a PiCCO system (PiCCO-2 Pulsion Medical Systems AG, Munich, Germany)

Exclusion Criteria

* Admission delay to ICU \> 24 hours post burn
* Age less than 18 years
* Pregnancy
* Chronic renal impairment with a baseline eGFR \< 15 ml/min
* Patients with chemical or electrical burns
* Coexisting non-burn trauma
* Patients moribund on admission or dead within 72 h from admission
* Patients with do-not-resuscitate orders

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No